Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Last Updated: June 4, 2023

Details for New Drug Application (NDA): 022437

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 022437 describes TRELSTAR, which is a drug marketed by Verity and is included in three NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the TRELSTAR profile page.

The generic ingredient in TRELSTAR is triptorelin pamoate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.
Summary for 022437
Ingredient:triptorelin pamoate
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 022437
Generic Entry Date for 022437*:
Constraining patent/regulatory exclusivity:

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Medical Subject Heading (MeSH) Categories for 022437
Suppliers and Packaging for NDA: 022437
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 022437 NDA Verity Pharmaceuticals Inc. 74676-5906 74676-5906-1 1 KIT in 1 CARTON (74676-5906-1) * 2 mL in 1 SYRINGE * 2 mL in 1 VIAL, SINGLE-DOSE (74676-5906-0)

Profile for product number 001

Approval Date:Mar 10, 2010TE:RLD:Yes
Patent:⤷  Try a TrialPatent Expiration:Jun 30, 2029Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.